Please login to the form below

Not currently logged in
Email:
Password:

Metrion Biosciences

This page shows the latest Metrion Biosciences news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: setback for Akcea/Ionis, Urovant adds gene therapy, Metrion gains funding

Daily Brief: setback for Akcea/Ionis, Urovant adds gene therapy, Metrion gains funding

Daily Brief: setback for Akcea/Ionis, Urovant adds gene therapy, Metrion gains funding. ... Metrion awarded £637k for ion channel drug discovery. Metrion Biosciences has been awarded £637, 000 funding under the Innovate UK Biomedical Catalyst Primer

Latest news

  • Appointments listing

    Metrion Biosciences establishes scientific advisory board. ... The board will provide scientific oversight and strategic advice to Metrion. .

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Metrion Biosciences adds to its board Metrion Biosciences adds to its board

    Metrion Biosciences adds to its board. Dr Barry Kenny and Dr Andrew Southan join the company. ... Dr Keith McCullagh, non-executive chairman of Metrion Biosciences, said: “I am delighted to welcome both Barry and Andy to Metrion’s board of directors.

  • Metrion Biosciences establishes scientific advisory board Metrion Biosciences establishes scientific advisory board

    Metrion Biosciences establishes scientific advisory board. The board will provide scientific oversight and strategic advice to Metrion. ... Contract research organisation and drug discovery business Metrion Biosciences has established a scientific

  • Metrion Biosciences expands operations team Metrion Biosciences expands operations team

    Metrion Biosciences expands operations team. Dr Andrew Southan appointed head of commercial operations. ... Cambridge, UK-based Metrion Biosciences has appointed Dr Andrew Southan as head of commercial operations.

  • Enterprise Therapeutics appoints CEO Enterprise Therapeutics appoints CEO

    Dr Ford also brings experience from Ario Pharma, where he is currently chief executive officer and co-founder, and Metrion Biosciences, where he serves as co-owner and investor director.

More from appointments
Approximately 3 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...

Infographics